Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws

被引:18
作者
Treister, Nathaniel S. [1 ,4 ]
Richardson, Paul [2 ]
Schlossman, Robert [2 ]
Miller, Kenneth [3 ]
Woo, Sook-Bin [1 ,4 ]
机构
[1] Brigham & Womens Hosp, Div Oral Med & Dent, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Cambridge, MA 02138 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2008年 / 105卷 / 06期
关键词
D O I
10.1016/j.tripleo.2008.02.010
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives. Bisphosphonate-associated osteonecrosis of the jaws (BONJ) is a recently recognized and well described complication in cancer patients. While pain and associated morbidity have been reported, this has largely been attributed to localized infection of the nonvital bone and surrounding soft tissue, or in rare cases, pathologic fracture. Study design. Cancer patients who were treated with intravenous bisphosphonate therapy and subsequently developed BONJ with associated traumatic tongue ulcerations were reported. Results. We report a series of 5 patients who presented with unilateral painful tongue ulcerations secondary to the tongue rubbing against adjacent exposed mylohyoid bone on the lingual surface of the mandible. Smoothing, recontouring, or removal of the bone, and in some cases intralesional steroid therapy, resulted in complete resolution of symptoms. Conclusions. Oral health care specialists and physicians must be alert to this potential complication of BONJ because it is easily managed with conservative measures and results in rapid and significant improvement in symptoms and overall quality of life.
引用
收藏
页码:E1 / E4
页数:4
相关论文
共 12 条
[2]  
[Anonymous], CANC FACTS FIG 2007
[3]   American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma [J].
Berenson, JR ;
Hillner, BE ;
Kyle, RA ;
Anderson, K ;
Lipton, A ;
Yee, GC ;
Biermann, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3719-3736
[4]   Recommendations for zoledronic acid treatment of patients with bone metastases [J].
Berenson, JR .
ONCOLOGIST, 2005, 10 (01) :52-62
[5]   Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices [J].
Doyle, Colleen ;
Kushi, Lawrence H. ;
Byers, Tim ;
Courneya, Kerry S. ;
Demark-Wahnefried, Wendy ;
Grant, Barbara ;
McTiernan, Anne ;
Rock, Cheryl L. ;
Thompson, Cyndi ;
Gansler, Ted ;
Andrews, Kimberly S. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2006, 56 (06) :323-353
[6]   The new bisphosphonate, Zometa® (Zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions:: A comparison to pamidronate [J].
Lipton, A ;
Small, E ;
Saad, F ;
Gleason, D ;
Gordon, D ;
Smith, M ;
Rosen, L ;
Kowalski, MO ;
Reitsma, D ;
Seaman, J .
CANCER INVESTIGATION, 2002, 20 :45-54
[7]   Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment [J].
Marx, RE ;
Sawatari, Y ;
Fortin, M ;
Broumand, V .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2005, 63 (11) :1567-1575
[8]   Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia [J].
Mavrokokki, Tony ;
Cheng, Andrew ;
Stein, Brien ;
Goss, Alastair .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (03) :415-423
[9]   Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone - An emerging oral complication of supportive cancer therapy [J].
Migliorati, CA ;
Schubert, MM ;
Peterson, DE ;
Seneda, LM .
CANCER, 2005, 104 (01) :83-93
[10]   Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases [J].
Ruggiero, SL ;
Mehrotra, B ;
Rosenberg, TJ ;
Engroff, SL .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (05) :527-534